Log in
Enquire now
Elixir Pharmaceuticals

Elixir Pharmaceuticals

Elixer Pharmaceuticals, no longer operating, was focused on the discovery, development, and commercialization of pharmaceuticals for treating metabolic diseases, such as diabetes and obesity.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/elixir-pha...maceuticals
CAGE Code
5H1S1
0
CIK Number
1,175,784
0
Company Operating Status
Closed
Crunchbase URL
crunchbase.com/organiz...euticals
DUNS Number
086956468
0
Industry
Biology
Biology
Diabetes mellitus
Diabetes mellitus
Biotechnology
Biotechnology
Technology
Technology
Investors
JAFCO Asia
JAFCO Asia
‌
Taiwan Global BioFund
YFY Biotech Management Company
YFY Biotech Management Company
Omega Funds
Omega Funds
Oxford Bioscience Partners
Oxford Bioscience Partners
ARCH Venture Partners
ARCH Venture Partners
MPM Capital
MPM Capital
IRS Number
61,549,431
0
Latest Funding Round Date
May 27, 2009
Latest Funding Type
Series D
Series D
LinkedIn URL
@company/elixir-pharmaceuticals/about
Location
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
Place of Incorporation
Delaware
Delaware
0
SIC Code
2,834
0
Total Funding Amount (USD)
58,000,000
Wellfound ID
elixir-pharmaceuticals

Find more companies like Elixir Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.